3D Impedimetric Biosensor for Cyanobacteria Detection in Natural Water Sources

The excessive growth of cyanobacteria in freshwater sources produces the development of toxic blooms mainly due to the production of cyanotoxins. Here, a novel impedimetric biosensor based on a three-dimensional interdigitated electrode array (3D-IDEA) for detection of cyanobacteria cells is reported. The 3D-IDEA sensor surface biofunctionalization was performed by means of the layer-by-layer method using polyethyleneimine (PEI) as the anchoring layer and concanavalin A (Con A) as the bioreceptor to lipopolysaccharides of cyanobacteria cells. The developed PEI-Con A 3D-IDEA sensors show a linear response (R2 = 0.992) of the impedance changes (RS) versus the logarithm of cyanobacteria concentrations in the range of 102–105 cells·mL−1 with the detection limit of 100 cells·mL−1. Moreover, to prevent the interference from components that may be present in real water samples and minimize a possible sample matrix effect, a filtration methodology to recover cyanobacterial cells was developed. The proposed methodology allows 91.2% bacteria recovery, permitting to obtain results similar to controlled assays. The developed system can be used in aquatic environments to detect cyanobacteria and consequently to prevent the formation of blooms and the production of cyanotoxins. Con A can bind to most polysaccharides and so react with other types of bacteria. However, currently, on the market, it is not possible to find specific biorecognition elements for cyanobacteria. Taking into consideration the specificity of samples to be analyzed (natural water resources), it is difficult to expect high concentration of other bacteria. In this sense, the developed methodology may be used as an alarm system to select samples for more thorough and precise laboratory analysis.

A SARS-CoV-2 aptasensor based on electrochemical impedance spectroscopy and low-cost gold electrode substrates.

SARS-CoV-2 diagnostic practices broadly involve either qPCR based nucleic amplification or lateral flow assays (LFAs). qPCR based techniques suffer from the disadvantage of requiring thermal cycling (difficult to implement for low-cost field use) leading to limitation on sample to answer time, the potential to amplify viral RNA sequences after a person is no longer infectious and being reagent intense. LFA performance is restricted by qualitative or semi-quantitative readouts, limits on sensitivity and poor reproducibility. Electrochemical biosensors, and particularly glucose test strips, present an appealing platform for development of biosensing solutions for SARS-CoV-2 as they can be multiplexed and implemented at very low cost at point of use with high sensitivity and quantitative digital readout. This work reports the successful raising of an Opti-mer sequence for the spike protein of SARS-CoV-2 and then development of an impedimetric biosensor which utilises thin film gold sensors on low-cost laminate substrates from home blood glucose monitoring. Clinically relevant detection levels for SARS-CoV-2 are achieved in a simple, label-free measurement format using sample incubation times of 15 minutes. The biosensor developed here is compatible with mass manufacture, is sensitive and low-cost CE marked readout instruments already exist. These findings pave the way to a low cost and mass manufacturable test with the potential to overcome the limitations associated with current technologies.